Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer
- PMID: 37655984
- DOI: 10.1002/ijc.34708
Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer
Abstract
Prostate cancer (PCa) is a highly heterogeneous disease in terms of its molecular makeup and clinical prognosis. The prostate tumor microenvironment (TME) is hypothesized to play an important role in driving disease aggressiveness, but precise mechanisms remain elusive. In our study, we used spatial transcriptomics to explore for the first time the spatial gene expression heterogeneity within primary prostate tumors from patients with metastatic disease. In total, we analyzed 5459 tissue spots from three PCa patients comprising castration-resistant (CRPC) and neuroendocrine (NEPC) disease stages. Within CRPC, we identified a T cell cluster whose activity might be impaired by nearby regulatory T cells, potentially mediating the aggressive disease phenotype. Moreover, we identified Hallmark signatures of epithelial-mesenchymal transition in a cancer-associated fibroblast (CAF) cluster, indicating the aggressive characteristic of the primary TME leading to metastatic dissemination. Within NEPC, we identified active immune-stroma cross-talk exemplified by significant ligand-receptor interactions between CAFs and M2 macrophages. Further, we identified a malignant cell population that was associated with the down-regulation of an immune-related gene signature. Lower expression of this signature was associated with higher levels of genomic instability in advanced PCa patients (SU2C cohort, n = 99) and poor recurrence free survival in early-stage PCa patients (TCGA cohort, n = 395), suggesting prognostic biomarker potential. Taken together, our study reveals the importance of whole transcriptome profiling at spatial resolution for biomarker discovery and for advancing our understanding of tumor biology.
Keywords: cancer-associated fibroblasts; immune checkpoint targets; metastatic prostate cancer; spatial gene expression; tumor microenvironment.
© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Similar articles
-
Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.Pathol Oncol Res. 2021 Sep 27;27:1609968. doi: 10.3389/pore.2021.1609968. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34646089 Free PMC article.
-
Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.Medicine (Baltimore). 2023 Aug 11;102(32):e34611. doi: 10.1097/MD.0000000000034611. Medicine (Baltimore). 2023. PMID: 37565899 Free PMC article.
-
A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data.Ann Med. 2023;55(2):2260387. doi: 10.1080/07853890.2023.2260387. Epub 2023 Sep 20. Ann Med. 2023. PMID: 37729607 Free PMC article.
-
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12. Eur Urol. 2014. PMID: 24321502 Review.
-
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).Crit Rev Oncog. 2022;27(1):1-24. doi: 10.1615/CritRevOncog.2022043478. Crit Rev Oncog. 2022. PMID: 35993976 Review.
Cited by
-
Application and new findings of scRNA-seq and ST-seq in prostate cancer.Cell Regen. 2024 Oct 29;13(1):23. doi: 10.1186/s13619-024-00206-w. Cell Regen. 2024. PMID: 39470950 Free PMC article. Review.
-
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.Biology (Basel). 2024 Sep 25;13(10):762. doi: 10.3390/biology13100762. Biology (Basel). 2024. PMID: 39452071 Free PMC article. Review.
-
Silencing SPP1 in M2 macrophages inhibits the progression of castration-resistant prostate cancer via the MMP9/TGFβ1 axis.Transl Androl Urol. 2024 Jul 31;13(7):1239-1255. doi: 10.21037/tau-24-127. Epub 2024 Jul 12. Transl Androl Urol. 2024. PMID: 39100821 Free PMC article.
-
Spatial transcriptomics in cancer research and potential clinical impact: a narrative review.J Cancer Res Clin Oncol. 2024 Jun 8;150(6):296. doi: 10.1007/s00432-024-05816-0. J Cancer Res Clin Oncol. 2024. PMID: 38850363 Free PMC article. Review.
-
Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer.Cell Death Dis. 2024 May 10;15(5):326. doi: 10.1038/s41419-024-06598-6. Cell Death Dis. 2024. PMID: 38729966 Free PMC article.
References
REFERENCES
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
-
- Lu-Yao GL, Potosky AL, Albertsen PC, Wasson JH, Barry MJ, Wennberg JE. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst. 1996;88(3-4):166-173. doi:10.1093/jnci/88.3-4.166
-
- Farach A, Ding Y, Lee M, et al. Neuronal trans-differentiation in prostate cancer cells. Prostate. 2016;76(14):1312-1325. doi:10.1002/pros.23221
-
- Andersen LB, Norgaard M, Rasmussen M, et al. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors. J Pathol. 2021;255:155-165. doi:10.1002/path.5757
-
- R core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria; 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical